Stock listing

NASDAQ:SCLN SciClone Pharmaceuticals Inc Stock

Follow SciClone Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SCLN

$11.15 USD

Close on Oct 13, 2017 · No longer trades

Dec 31, 1997 to last close +224.3% · monthly closes, Dec 31, 1997 – Oct 13, 2017
Lowest – highest close
$0.68 – $20.63 USDSince Dec 31, 1997 · lowest Dec 30, 2008 · highest Mar 7, 2000

Delisted NASDAQ:SCLN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SCLN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

SciClone Pharmaceuticals Inc on 6ix

Decks
3 decks · latest Jan 7, 2013

Where SciClone Pharmaceuticals Inc is listed

ListingExchangeCountryCurrency
NASDAQ:SCLN · This page · DelistedNASDAQUnited StatesUSD
HKEX:6600 臥安機器人 · DelistedHKEXHong KongHKD

Decks

DeckKindSlidesDate
Investor Presentation (January 2013)Investor deck22 slidesJan 7, 2013
Investor Presentation (January 2010)Investor deck22 slidesJan 11, 2010
Proxy Contest (February 2009)Proxy contest35 slidesFeb 9, 2009

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Anthony Gregg Lapointe
Other companies: Astria Therapeutics Inc (Director · Since at least Jan 3, 2019); Rigel Pharmaceuticals, Inc. (Director · Since at least Oct 31, 2017); Soligenix, Inc. (Director · Since at least Mar 10, 2009); Raptor Pharmaceutical Corp (Director · Jan 1, 2015 – Oct 24, 2016 · Past); Questcor Pharmaceuticals Inc (Director · Oct 9, 2009 – Jan 1, 2010 · Past)
Director · Mar 30, 2009 – Oct 13, 2017 · Past
Richard J. Hawkins
Other companies: Plus Therapeutics, Inc. (Director · Since at least Jun 25, 2020); Savara, Inc. (Audit Committee · Since at least Dec 17, 2017); Lumos Pharma Inc (Chief Executive Officer, Director · Mar 18, 2020 – Dec 12, 2024 · Past)
Director · Oct 13, 2017 – Oct 13, 2017 · Past
Israel RiosSr. VP, Medical Affairs & CMO · Mar 13, 2012 – Mar 15, 2012 · Past

Open People

Log in to ask 6ix AI your own questions about SciClone Pharmaceuticals Inc.